Cargando…
Pattern of Recurrence After Platinum-Containing Definitive Therapy and Efficacy of Salvage Treatment for Recurrence in Patients with Squamous Cell Carcinoma of the Head and Neck
BACKGROUND: In first-line systemic therapy for unresectable recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN), regimens are generally selected by time-to-relapse with 6 months cutoff after platinum (Pt)-containing definitive therapy, Pt-refractory or Pt-sensitive r...
Autores principales: | Wakasugi, Tetsuro, Nguyen, Thi Nga, Takeuchi, Shoko, Ohkubo, Jun-ichi, Suzuki, Hideaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289148/ https://www.ncbi.nlm.nih.gov/pubmed/35860589 http://dx.doi.org/10.3389/fonc.2022.876193 |
Ejemplares similares
-
The Current Role of Salvage Surgery in Recurrent Head and Neck Squamous Cell Carcinoma
por: Hamoir, Marc, et al.
Publicado: (2018) -
Opportunities and Limits in Salvage Surgery in Persistent or Recurrent Head and Neck Squamous Cell Carcinoma
por: Huber, Gerhard Frank
Publicado: (2021) -
Review of Outcomes after Salvage Surgery for Recurrent Squamous Cell Carcinoma of the Head and Neck
por: Hartl, Dana M., et al.
Publicado: (2023) -
Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
por: Wakasaki, Takahiro, et al.
Publicado: (2020) -
Outcome in recurrent head neck cancer treated with salvage-IMRT
por: Studer, Gabriela, et al.
Publicado: (2008)